Navigation Links
Growing Popularity of Cholesterol-lowering Drugs Raises Concern

A novel analysis about the usage of cholesterol lowering drugs has revealed the trend of healthy people using this drug as a means to prevent heart disease; Researchers warn// that these drugs are to be employed only to lower life-threatening health risks for those suffering vascular disease.

Popularly called statins, these drugs are beneficial in reducing the risk of heart attack and cardiovascular problems in patients suffering artery disease. The analysis revealed the most disconcerting aspect, that 75% of its users did not portray substantial evidence of vascular disease, to warrant a cholesterol lowering drug.

‘It's not a trivial, minor thing. It's the bulk of the prescribing,’ says Dr. Jim Wright, a professor at the University of B.C.

Wright and co-author Dr. John Abramson of Harvard Medical School, collated data from eight randomized trials that endeavored to compare statins with a placebo - in people who suffered a high risk of cardiovascular disease. The study revealed that statins did not make an impact in reducing the number of deaths. Further there was no palpable benefit to women.

In totality, researchers said that statins did bring down the risk of heart attack or stroke. But the complete risk cover was only about 1.5%, which is very little, researchers opined. Upon closer observation, the gains appeared to reflect only in the high risk category.

‘Most people have the impression that statins are going to make them live longer. For primary prevention, there hasn't been demonstrated to be any survival advantage,’ Wright said.
SV
'"/>




Page: 1

Related medicine news :

1. Problems Of a Growing Company
2. Growing trend of delay in completing vaccination schedule
3. Growing tissues
4. Women Growing Up In Poverty At Increased Risk Of Heart Disease
5. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
6. Extensive Campaigning To Warn Against Children’s Growing Affinity To Fast Food In Britai
7. Another Potential Of Stem Cells Discovered: Used For Growing Cartilage
8. Americans Growing Out Of Shape
9. Kids Face a Slim Chance of Growing Obese, If Breastfed Longer Than Three Months
10. Breast Cancer Survivors Growing in Numbers
11. Growing Drug Addiction Rate among Elderly Population
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: